Anti-HIV agents. Atazanavir vs. Kaletra.
D000328:Adult; D000069446:Atazanavir Sulfate; D018791:CD4 Lymphocyte Count; D002784:Cholesterol / Q000097:blood; D005260:Female; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008099:Liver / Q000201:enzymology; D061466:Lopinavir; D008297:Male; D009842:Oligopeptides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011744:Pyrimidinones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood; D019562:Viral Load
D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D011744:Pyrimidinones; D014280:Triglycerides; D061466:Lopinavir; D000069446:Atazanavir Sulfate; D002784:Cholesterol